Apr 08, 2024
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Feb 13, 2024
Onkos Surgical Presents at the Canaccord Genuity 2024 Musculoskeletal Healthcare Conference
Feb 05, 2024
Onkos Surgical to Present at Canaccord Genuity's 2024 Musculoskeletal Conference
Feb 06, 2020
Onkos Surgical® announces the launch of GenVie(TM), a novel Magnesium Bone Scaffolding technology
Jan 21, 2020
Onkos Surgical® partners with Integrum® to expand US market for the OPRA(TM) Implant System; a revolutionary osseointegration and bone-anchored prosthetic technology
Sep 26, 2019
3D Systems' VSP Orthopaedics Receives FDA 510(k) Clearance -- Opening the Door to Personalized Treatment of Complex Musculoskeletal Disease
Aug 28, 2019
Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology
Jul 15, 2019
Onkos Surgical® and The Sarcoma Foundation of America to Sponsor Upcoming Cancer Awareness Fundraiser
Mar 14, 2019
Onkos Surgical® Announces Partnership with Promimic AB for Development of Hydroxyapatite Surface Technology in Limb Salvage Surgery
Mar 12, 2019
Onkos Surgical® Set to Deliver on Promise of Innovation with 7 New Products Scheduled to Launch in 2019
Mar 06, 2018
Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions
Sep 27, 2017
Onkos Surgical® Launches Precision Oncology Platform at 2017 Annual Musculoskeletal Tumor Society Meeting in Denver, Colorado